When does the Zoladex patent expire?
The provided information does not include any Zoladex (goserelin) patent expiry dates. Patent expiry depends on the specific patent family, jurisdiction (country), and whether additional exclusivities apply (for example, supplementary protection certificates in the EU).
Which patents matter for Zoladex—primary patents or exclusivity extensions?
Patent expiry timelines usually hinge on more than one protection layer:
- Primary (marketing/compound/formulation/use) patents in each country.
- Patent “family” status (different patents in the same family can expire at different times).
- Patent term adjustments/extensions or compensations (country-specific).
- Additional regulatory exclusivities (for example, supplementary protection certificates in Europe), which can extend market exclusivity beyond the base patent.
To answer precisely, you would need the patent numbers (or at least the jurisdiction and reference product label/active ingredient) being considered.
How can I find the exact Zoladex expiry date for a specific country?
The fastest way is to identify the product’s active ingredient (goserelin) and then check:
- The national patent register for the relevant patent family.
- Official “patent expiry / dossier” tools used by regulators or medicine-data services (if you have access).
- For Europe specifically, supplementary protection certificate (SPC) databases and the underlying basic patent number.
Does expiry differ by indication or dosage form?
Yes. Even for the same active ingredient, exclusivity can differ if patents cover:
- Specific indications (for example, prostate cancer vs. other approved uses).
- Specific formulations or dosing schedules (Zoladex is known for implant formulations; exact protection can be formulation- or method-specific).
- Specific manufacturing processes (process patents are jurisdiction- and claim-dependent).
What happens if patents expire—will generics or biosimilars enter immediately?
If patents (and other exclusivities like SPCs) expire, generic manufacturers may still be restricted by other protections that can exist in parallel, such as:
- Additional later-expiring patents in the same family (or new “evergreening” filings).
- Litigation or regulatory stays in some jurisdictions.
- Requirement for bioequivalence and regulatory review timing.
Sources
No sources were provided with the question, so no verified patent expiry date can be cited.